Cagrilintide
Product Details
Cagrilintide — Research Peptide
Cagrilintide is a long-acting amylin analog commonly studied in laboratory settings for its interaction with amylin receptor pathways, metabolic signaling mechanisms, and appetite-regulation research models. Structurally designed to mimic the activity of the endogenous hormone amylin, Cagrilintide has been investigated for its role in peptide-mediated metabolic communication and endocrine signaling pathways.
Scientific literature has explored Cagrilintide in studies involving glucose regulation pathways, gastric signaling mechanisms, metabolic homeostasis, and neuroendocrine communication systems. Additional research has examined how amylin analogs interact with receptor-mediated signaling processes associated with energy balance and metabolic pathway regulation.
Published studies have investigated Cagrilintide in laboratory models involving peptide hormone signaling, metabolic regulation, cellular communication pathways, and endocrine system research. Research has also explored its role in amylin receptor activity and biochemical signaling analysis.
This compound is supplied for qualified laboratory research and analytical purposes only.
Product Details
Product Name: Cagrilintide
Form: Lyophilized peptide powder
Grade: Research use only
Application: Laboratory research and analytical testing only
Storage: Store in a cool, dry place under proper laboratory storage conditions.
Research Areas
This compound may be used in research related to:
- Amylin receptor signaling pathway studies
- Metabolic and endocrine signaling research
- Glucose regulation and metabolic homeostasis investigation
- Peptide-mediated cellular communication analysis
- Neuroendocrine pathway and receptor activity studies
- Energy balance and biochemical signaling research
- Molecular and metabolic pathway investigation
Research References
- Lau DCW, Erichsen L, Francisco AM, et al. “Once-weekly cagrilintide for weight management.” The Lancet.
- Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD. “Amylin: pharmacology, physiology, and therapeutic potential.” Pharmacological Reviews.
- Srivastava G, Apovian CM. “Current pharmacotherapy for obesity.” Nature Reviews Endocrinology.
Important Disclaimer
For research use only. Not for human use. Not for animal use. Not for consumption, injection, ingestion, cosmetic use, medical use, veterinary use, or therapeutic application. This product is not intended to diagnose, treat, cure, or prevent any disease. Must be handled only by qualified professionals in a controlled laboratory setting.
Due to current demand and supply availability, peptide vial cap colors may vary. Cap color is determined by available laboratory packaging materials and does not indicate any difference in product identity, specifications, or quality.
Lorem ipsum dolor ist amte, consectetuer adipiscing eilt. Aenean commodo ligula egget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quak felis, ultricies nec, pellentesque eu, pretium quid, sem.
